{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:14:19Z","timestamp":1787764459985,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Canadian Collaborative Research Network"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.atherosclerosis.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T20:01:33Z","timestamp":1496520093000},"page":"112-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management"],"prefix":"10.1016","volume":"263","author":[{"given":"G.B.John","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Tsigoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib1","first-page":"1263","article-title":"2016 canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib2","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1-executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.06.006_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4158\/EP171764.GL","article-title":"American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib5","author":"National Vascular Disease Prevention Alliance"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib6","first-page":"1","article-title":"I\u00a0brazilian guidelines on cardiovascular prevention","volume":"101","author":"Simao","year":"2013","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib8","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib9","first-page":"837","article-title":"Canadian cardiovascular society guidelines for the diagnosis and management of stable ischemic heart disease","volume":"30","author":"Mancini","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib10","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib11","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2013.11.009","volume":"63","author":"Wolk","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/abc.2014S004","article-title":"Guideline for stable coronary artery disease","volume":"103","author":"Cesar","year":"2014","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/euhj.2002.3194","article-title":"Task force on the management of chest pain","volume":"23","author":"Erhardt","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib15","author":"National Institute for Health and Care Excellence"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2017.06.006_bib16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jacc.2016.03.519","volume":"68","author":"Lloyd-Jones","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw480","article-title":"European Society of Cardiology\/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin\/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk","author":"Landmesser","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib19","author":"National institute for Health and Care Excellence"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib20","author":"National institute for Health and Care Excellence"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2016.12.018","article-title":"Planning a research agenda to incorporate imaging into clinical practice","author":"Robinson","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib22","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.116.022134","article-title":"Moving toward the next paradigm for cardiovascular prevention","volume":"133","author":"Robinson","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.06.006_bib23","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jacc.2016.09.928","article-title":"Determining when to add nonstatin therapy: a quantitative approach","volume":"68","author":"Robinson","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017302551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:36:51Z","timestamp":1758155811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017302551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":23,"alternative-id":["S0021915017302551"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}